Notebook

The National Science Foundation has joined the National Institutes of Health in considering changes to its peer-review system of rating grant applications (T.W. Durso, The Scientist, Dec. 9, 1996, page 1). NSF's current four-criteria system-assessing research performance and competence, intrinsic merit, utility or relevance, and the research's effect on science and engineering infrastructure-has been in place since 1981. NSF officials say it's time to revisit the criteria and that the proposed

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

The National Science Foundation has joined the National Institutes of Health in considering changes to its peer-review system of rating grant applications (T.W. Durso, The Scientist, Dec. 9, 1996, page 1). NSF's current four-criteria system-assessing research performance and competence, intrinsic merit, utility or relevance, and the research's effect on science and engineering infrastructure-has been in place since 1981. NSF officials say it's time to revisit the criteria and that the proposed changes would be clearer to applicants and easier for them to respond to. The new, two-part system, recommended by a Task Force on Merit Review established by the National Science Board (NSB), NSF's governing body, would require applicants to describe the "intellectual merit and quality" of their proposals, as well as their "broader impacts." The proposal is posted on NSF's Web site (http://www.nsf.gov), where researchers can respond with their views. Comments also can be E-mailed to meritrev@nsf.gov and are ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies